Guidance on vaccination of HIV-infected children in Europe.
about
Immunization of children with secondary immunodeficiencyPneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Immunization of HIV-infected adult patients - French recommendations.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.Premature ageing of the immune system relates to increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1-infected and kidney-transplanted patients.Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.
P2860
Q26801474-4F2CDA34-DAAB-4E47-8667-9C7A0CDE5A26Q28070059-DBEA4C7D-3683-4EF5-A8D8-DFD28FB5E636Q34196888-BA469405-3F7D-4EAB-8729-C0AAA713E3DCQ35680467-5AE9D091-52AE-4420-A686-20D2991A6643Q35887330-C45A4749-B197-45A3-B8E6-6FE8D9EAC064Q37029106-5BEA2A25-9735-423C-A9A2-4296CA9D4DBFQ38036063-190AFE6C-A3F5-446D-B038-9792EB20E8D9Q38198120-7538F1C4-5175-4027-9826-C5BF38E0103EQ40615516-72AD0324-3993-48FE-8DE2-A47D0818F27DQ41505058-28250D82-37F9-4A45-9658-A52FA0DB5BF1Q41927775-CA858ADF-75E4-4E8B-BE48-63203722894AQ42255696-46CAB41A-0068-42F0-AA3F-9D0AB0351C44Q47579533-36DEF17A-6F42-4354-BBE3-F27999D48005
P2860
Guidance on vaccination of HIV-infected children in Europe.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Guidance on vaccination of HIV-infected children in Europe.
@ast
Guidance on vaccination of HIV-infected children in Europe.
@en
Guidance on vaccination of HIV-infected children in Europe.
@nl
type
label
Guidance on vaccination of HIV-infected children in Europe.
@ast
Guidance on vaccination of HIV-infected children in Europe.
@en
Guidance on vaccination of HIV-infected children in Europe.
@nl
prefLabel
Guidance on vaccination of HIV-infected children in Europe.
@ast
Guidance on vaccination of HIV-infected children in Europe.
@en
Guidance on vaccination of HIV-infected children in Europe.
@nl
P2093
P2860
P1433
P1476
Guidance on vaccination of HIV-infected children in Europe
@en
P2093
Children's HIV Association (CHIVA)
D Duiculescu
E N Menson
H J Scherpbier
M L Navarro
M J Mellado
PENTA Steering Committee
Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group
P2860
P304
333-6; e1-14
P356
10.1111/J.1468-1293.2011.00982.X
P577
2012-02-02T00:00:00Z